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Abstract
Aim: The cAMP-mediator Epac1 (RapGef3) has high renal expression. Preliminary 
observations revealed increased diuresis in Epac1−/− mice. We hypothesized that 
Epac1 could restrict diuresis by promoting transcellular collecting duct (CD) water 
and urea transport or by stabilizing CD paracellular junctions to reduce osmolyte loss 
from the renal papillary interstitium.
Methods: In Epac1−/− and Wt C57BL/6J mice, renal papillae, dissected from snap-
frozen kidneys, were assayed for the content of key osmolytes. Cell junctions were 
analysed by transmission electron microscopy. Urea transport integrity was evalu-
ated by urea loading with 40% protein diet, endogenous vasopressin production was 
manipulated by intragastric water loading and moderate dehydration and vasopressin 
type 2 receptors were stimulated selectively by i.p.-injected desmopressin (dDAVP). 
Glomerular filtration rate (GFR) was estimated as [14C]inulin clearance. The glo-
merular filtration barrier was evaluated by urinary albumin excretion and microvas-
cular leakage by the renal content of time-spaced intravenously injected 125I- and 
131I-labelled albumin.
Results: Epac1−/− mice had increased diuresis and increased free water clearance 
under antidiuretic conditions. They had shorter and less dense CD tight junction (TJs) 
and attenuated corticomedullary osmotic gradient. Epac1−/− mice had no increased 
protein diet-induced urea-dependent osmotic diuresis, and expressed Wt levels of 
aquaporin-2 (AQP-2) and urea transporter A1/3 (UT-A1/3). Epac1−/− mice had no 
urinary albumin leakage and unaltered renal microvascular albumin extravasation. 
Their GFR was moderately increased, unless when treated with furosemide.
Conclusion: Our results conform to the hypothesis that Epac1-dependent mecha-
nisms protect against diabetes insipidus by maintaining renal papillary osmolarity 
and the integrity of CD TJs.
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1 |  INTRODUCTION
The second messenger cAMP has two generally expressed 
mediators: The cAMP-dependent protein kinase (PRKAC/R; 
PKA) and the cAMP-activated Rap GDP exchange factors 
Epac1 and Epac2 (RapGef3, 4).1-5 Epac1 (RapGef3) has high 
renal expression.6-8 We noted earlier that our Epac1−/− mice 
had ‘wet’ cages caused by increased diuresis.9 The available 
evidence summarized below suggested two working hypothe-
ses for how Epac1 could limit diuresis: (a) by enhancing urea 
and water transport in the collecting duct (CD); and (b) by 
regulating CD tight junction (TJ) integrity to minimize os-
molyte loss from the renal papillary interstitium.
In vitro studies using the Epac-stimulating cAMP ana-
logue 8-pPCT-2′-O-Me-cAMP10,11 suggest that Epac can 
stimulate transcellular urea transport,5,12,13 maintain high 
aquaporin-2 (AQP-2) synthesis5,14 and stimulate the insertion 
of AQP-2 in the principal cell (PC) apical membrane.15
8-pPCT-2′-O-Me-cAMP has numerous ‘off-target’ ac-
tions. It can affect purinergic receptors or transmembrane 
transporters and indirectly activate PKA by inhibiting cAMP 
degradation.16,17 To evaluate specific Epac1 actions, the pres-
ent study compares Wt and Epac1 null mice. The Epac1−/− 
mice have been described previously and do not express 
Epac1 in any tested tissue, including kidney.7
Early data based on immunofluorescence suggested high 
Epac1 expression in the proximal tubules and the intercalated 
cells (IC) of the CD.9 More recent, quantitative transcrip-
tomic studies indicate low expression in proximal tubules and 
high expression in renal glomeruli and the CD,6 whose PC 
express more RapGef3 than the ICs.10
The reports that Epac1 contributes to the cAMP induction 
of urea transporters5,11,12 imply that Epac1 can protect against 
urea-induced osmotic diuresis. If so, a high protein load14,18 
should induce more severe diuresis in the Epac1−/− mice. We 
compared, therefore, the diuresis of Wt and Epac1−/− mice 
on low (4%), standard (12.5%) or high (40%) protein diet, 
and determined if Epac1-deficient mice had altered expres-
sion of the major urea transporter (UT-A1). We determined 
also whether their AQP-2 expression was decreased based on 
reports that Epac1 may contribute to enhanced AQP-2 syn-
thesis or stability.5,14
The high Epac1 expression in renal glomeruli6 suggests 
that Epac1 can affect glomerular function. We tested, there-
fore, if the Epac1 null mice had deficient glomerular filtra-
tion barrier, or had altered glomerular filtration rate (GFR) 
in the absence or presence of the tubuloglomerular feedback 
(TGF)19,20 blocker furosemide.19,21
Several Epac1−/− mouse organs have increased basal in 
vivo microvascular permeability,7,22 indicating that Epac1 can 
limit fluid extravasation. We hypothesized that Epac1 might 
act to conserve intravascular fluid also via renal actions. We 
therefore compared the diuresis of Wt and Epac1−/− mice 
not only under basal conditions, but also after water loading 
(WL) when endogenous AVP is low,23 after moderate water 
deprivation and after injection of the avpr2 receptor agonist 
desmopressin (dDAVP).
A number of observations suggest that the CD cell junc-
tional complexes (JCs) could be targets for regulation by 
Epac1. Firstly, Epac1 is well known to strengthen cell junc-
tions in vitro24,25 and in vivo.7 Secondly, Epac1 and its major 
downstream target E-cadherin have higher expression in the 
CD than in other parts of the rat nephron, as shown by deep 
sequencing of mRNA from dissected rat nephron segments.6 
The importance of E-cadherin for an intact CD barrier and 
ability to concentrate urine are demonstrated by mice with 
downregulated Grainyhead-like protein 2 homolog (GRHL2). 
They express less key junctional proteins and have diabetes 
insipidus as well as decreased renal medullary Na+ content.26 
We therefore determined the Na+ content in snap-frozen 
renal papillae from Wt and Epac1−/− mice and studied the 
CD junctions by transmission electron microscopy (TEM).
2 |  RESULTS
2.1 | Epac1−/− mice have increased diuresis 
at normal and low urea load
The deletion of Epac1 did not impact kidney weight (average 
262 mg in Wt and 263 mg in Epac1−/− mice), kidney-to-BW 
ratio (10.3 mg g−1 in either Wt or Epac1−/−) or gross renal 
morphology (Table S1, Figure S1). However, cages housing 
Epac1−/− mice were consistently ‘wetter’ than cages housing 
Wt mice under standard breeding conditions. Specifically, 
Epac1 null mice housed in metabolic cages with free access to 
standard (12.5%) protein chow and drinking water had more 
than twice as high diuresis as matched Wt mice (Table 1).
To test whether the increased Epac1−/− mouse diuresis was 
related to deficient handling of urea, we compared the effect 
of low (4%) and high (40%) protein. The diuretic phenotype 
was strongest at 4% protein diet (Table 2A). The 40% protein 
K E Y W O R D S
collecting duct, diabetes insipidus, exchange protein directly activated by cAMP (Epac1, RapGef3), GFR, 
occluding junction, vasopressin (AVP)
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feeding led, as expected,27 to increased diuresis in both Wt and 
Epac1−/− mice, but it did not enhance the Epac1−/− diuretic 
phenotype (Table 2B). Further, switching from 4% to 40% pro-
tein had opposite effects in Epac1-deleted and UT-A1/3-deleted 
mice27 regarding water consumption, urine production and 
urine osmolarity (Figure S2). The level of UT-A1/3 (Slc14a2) 
mRNA was similar in Wt and Epac1−/− mice both 3 hours after 
WL and 6 hours after WL and dDAVP injection (Figure S3A).
The increased diuresis of the Epac1−/− mice at low or 
moderate protein load was matched by increased water in-
take (Tables 1 and 2A) resulting in similar retention of water 
for either strain. To rule out any effect of compulsory drink-
ing behaviour, mice were denied access to drinking water. 
Dehydration was counteracted by intragastric infusion of 1.5-
mL water (WL) at the onset of each experiment. We found a 






Body weight (g) 20.4 (SD1.3) 21.4 (SD1.9)
Water consumption (µL 24h−1 g−1) 195 (SD110) 242 (SD81)
Urine output (µL 24h−1 g−1) 59.8 (SD15) 130 (SD33)aaaa
Urine osmolality (mOsm kg−1 H2O) 1770 (SD698) 1360 (SD808)
Osm excr.(nosm min−1 g−1) 77.8 (SD23.6) 146 (SD93.7)
Urine urea conc. (mmol/L) 1330 (SD520) 1150 (SD713)
Urea excr. (nmol min−1 g−1) 64.1 (SD15.9) 60.7 (SD24.6)
The mice were kept in metabolic cages for 24 h with free access to drinking water and chow containing 12.5% 
protein. Urine was continuously sampled throughout the 24-h period. The table shows the mean (SD) water 
consumption (n = 13-14), urine output (n = 13-14) and selected urinary parameters (n = 6). Unpaired two-
tailed Student's t test with Welch’s correction or non-parametric Mann-Whitney test was used to determine 
statistical differences between the diuresis of Wt and Epac1−/− mice, aaaaP < .0001, sum of ranks 105, 273, 
Mann-Whitney U = 0.
T A B L E  1  24-h baseline water 
consumption, diuresis and key urinary 
parameters for Wt and Epac1−/− mice fed 
standard (12.5%) protein diet
T A B L E  2  Urinary Parameters for Wt and Epac1−/− mice on low (4%) and high (40%) protein diet
Variable determined
(A) Low protein diet (4%) (B) High protein diet (40%)
WT Epac1−/− WT Epac1−/−
Body weight (g) 19.7 (SD2.1) 21.1 (SD2.1) 19.0 (SD3.1) 21.8 (SD1.8)
Water consumed (µL 24h−1 g−1) 110 (SD24) 179 (SD18)aa 227 (SD42) 239 (SD60)
Urine output (µL 24h−1 g−1) 50.6 (SD13) 110 (SD14)bbb 165 (SD68.4) 181 (SD54.7)
Urine Urea (mmol/L) 874 (SD219) 504 (SD146)c 2667 (SD434) 2619 (SD1389)
Urine Na+ (mmol/L) 154 (SD37) 68 (SD5)d 42 (SD9) 37 (SD8)
Urine K+ (mmol/L) 262 (SD71) 138 (SD14)e 108 (SD23) 92 (SD26)
Urine Creatinine (mmol/L) 3.56 (SD1.00) 1.82 (SD0.12)f 1.27 (SD0.48) 1.18 (SD0.32)
Urine osm. (mosm kg−1) 2091 (SD468) 1046 (SD128)gg 4249 (SD903) 3268 (SD554)
Urea excr. (nmol min−1 g−1) 31.9 (SD7.0) 38.0 (SD7.6) 290 (SD82) 298 (SD68)
Na+ excr. (nmol min−1 g−1) 5.32 (SD1.04) 5.24 (SD0.56) 4.45 (SD0.92) 4.53 (SD0.93)
K+ excr. (nmol min−1 g−1) 9.37 (SD1.5) 10.6 (SD0.88) 11.1 (SD2.62) 11.0 (SD1.78)
Creat. excr. (pmol min−1 g−1) 117 (SD13) 140 (SD15.7) 128 (SD8.4) 139 (SD17.4)
Plasma urea (mmol/L) 2.1 (SD0.23) 2.0 (SD0.13) 3.6 (SD0.42) 2.9 (SD0.39)
Plasma creatinine (μmol/L) 7.8 (SD0.5) 7.3 (SD2.0) 6.1 (SD0.9) 5.4 (SD2.0)
Urea clearance (μL min−1) 74 (SD15) 104 (SD19)h 402 (SD99) 569 (SD130)
Creatinine clearance (μL min−1) 360 (SD57) 447 (SD29) 418 (SD17) 512 (SD66)
Wt (n = 4-5) and Epac1−/− mice (n = 4- 5) were first (A) fed 7 d 4% protein diet followed by 24 h determination of water intake and diuresis, and next (B) 7 d 40% 
diet followed by similar monitoring. The results are given as mean (SD), and excretion data are normalized per g body weight. Unpaired two-tailed Student's t test with 
Welch’s correction when applicable, was used to determine statistical differences between the diuresis of Wt and Epac1−/− mice, aaP = .0035, bbbP = .0007, cP = .031, 
dP = .018, eP = .037, fP = .039, ggP = .0051, hP = .044).
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Wt mice (Table S2, 4% protein feeding), especially between 
3 and 6 hours after WL (Figure 1A,B).
2.2 | Epac1−/− mice have impaired urinary 
concentrating capacity under antidiuretic 
conditions, but intact dDAVP-induced 
increase of cAMP and AQP-2
The water-loaded Wt and Epac1−/− mice had similar diuresis 
until the WL had been eliminated (Figure 1A). Only there-
after did the Epac1−/− mice have higher urine excretion than 
Wt mice (Figure 1A,B). To test whether Epac1−/− mice were 
subresponsive to AVP, they were given a bolus injection of 
dDAVP. Although both Wt and Epac1−/− mice had a period 
of complete anuria after dDAVP + WL, the diuresis recov-
ered slightly earlier for Epac1−/− than for Wt mice (Figure 
1A,B). Analysis of the urine revealed that the Epac1 null 
mice had higher free water clearance than Wt mice (Figure 
1C).
The subresponsiveness of the Epac1 null mice to AVP/
dDAVP could be due to deficient Avpr2-mediated increase of 
cAMP or of AQP-2. Both cAMP excretion (Figure 1D,E) and 
expression of Aqp2 mRNA or AQP-2 protein (Figure S3B-D) 
were similar in Wt and Epac1−/− mice, under basal conditions 
as well as after dDAVP stimulation.
F I G U R E  1  Epac1−/− mice have higher diuresis and spare less free water than Wt mice under antidiuretic conditions. (A) Accumulative 
diuresis during the first 6 h after water loading (WL) alone or after injection of dDAVP. The horizontal hatched line represents the volume (1.5-mL 
H2O + 0.1-mL saline) loaded, n = 6-7 mice/group, 
*P = .016 at 5h, *P = .015 at 5.5 h and *P = .015 at 6 h. (B) The diuresis between 3 and 6 h 
after WL alone and between 5 and 6 h for WL + dDAVP, n = 5-6 mice/group, †P = .0058 for vehicle and *P = .045 for dDAVP. (C) Free water 
clearance (μL min−1), n = 6 mice/group, P = .69 for vehicle and *P = .023 for dDAVP. (D) cAMP excretion (pmol min−1), n = 5-7 mice/group, 
F(1, 20) = 0.043, P = .84 for interaction and ‡P = .0003 for treatment (E) cAMP excretion (pmol min−1) for control mice, n = 5-7 mice/group, 
P = .58. Values are presented as mean ± SEM (panel A) or as both mean (SD) and mean (SEM) (panels B-E). Unpaired two-tailed Student's t 
test with Welch’s correction when applicable (A-C, E) or two-way ANOVA with Tukey's adjustment for multiple comparisons (D) was used to 
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2.3 | Epac1−/− mice have lower papilla and 
bladder urine osmolarity than Wt mice under 
antidiuretic conditions
The Epac1−/− mouse water-sparing deficiency could be 
explained by a perturbed renal corticopapillary osmotic 
gradient. The length of the renal papillary tip as well as 
the thickness of the papillary base, medulla and cortex 
appeared similar in Epac1−/− and Wt mice upon dissec-
tion. Moreover, the papillary blocks, dissected in the same 
way from Wt and Epac1−/− mice, had similar average dry 
weight (Figure 2A).
The water content increased significantly from cor-
tex to papilla for either Epac 1−/− mice (74.3%-83.8%, 
‡P  <  .001) or Wt mice (73.8%-80.8%, †P  =  .004), but 
slightly more so (by about 9.5%) for Epac1 null mice than 
(about 7%) for Wt mice (Figure 2B). More strikingly, the 
papillary Na+ content of Epac1−/− was only 53% of that in 
Wt (Figure 2C).
To evaluate whether the difference was related to less en-
dogenous AVP stimulation in the Epac1−/− mice, the plasma 
Na+ concentration and osmolarity were determined. We 
found similar values for Epac1−/− (152(SD6) mmol/L Na; 
324(SD7) mosm Kg−1) and Wt mice (152(SD3) mmol/L Na; 
328(SD8) mosm Kg−1).
To establish the correlation between papillary and urine 
content of osmolytes, we analysed also the urine aspirated 
from the bladder of overnight water-deprived mice just be-
fore the kidney sampling. The urine from Epac1−/− mice 
had only 59% (SD18) as high urea concentration and 58% 
(SD14) as high osmolarity as Wt mouse urine (Figure 3). 
The reduction of the urine concentration of the various os-
molytes was similar to the reduction of Na+ in the papilla 
(Figures 2 and 3).
2.4 | Epac1−/− and WT mice have similar 
extravasation of albumin
In a previous study, Epac1−/− mice had increased leakage 
from microvessels in skin, intestine and skeletal muscle as 
measured using the double isotope 125I-HSA and 131I-HSA 
injection method (see Ref. 7 for details). We found no dif-
ference in albumin permeability between Wt and Epac1−/− 
mice. The Epac1−/− mice also failed to increase permeability 
in response to ANP, which increases albumin permeability in 
Wt mouse skin, muscle and intestine7 (Figure 4A,B).
2.5 | The CD TJs are shorter and less dense 
in Epac1−/− than in Wt mice
The corticopapillary osmotic gradient perturbation of Epac1 
null mice (Figures 2 and 3) resembled that reported in mice 
with genetically induced CD TJ ‘leakiness’ associated with less 
E-cadherin expression.26 The striking CD clustering of mRNA 
coding for Avpr2, Epac1 and the downstream Epac1 target 
E-cadherin6 (Table S3) prompted a study of the CD junctions. To 
know if the Epac1 null mice had altered CD JCs, we compared 
Epac1−/− mouse CD junctions with Wt controls using TEM.
Epac1−/− and Wt CD had similar general paracellular or-
ganization (see Figure 5 for representative examples), with an 
apical TJ that merges into a JC. Morphometric analysis of 56 
PC/PC junctions from six Wt mice and 51 PC/PC junctions 
from five Epac1−/− mice revealed that compared to Wt the 
Epac1−/− TJs were on average shorter, less dense (had higher 
electron transmittance) and associated with less electron-dense 
junctional material (Table S4, Figure 6A-C). A similar, but less 
strong, trend was found for the JC (Table S4). Table S4 lists also 
the percentage of each TJ appearing to be ‘open’, as subjectively, 
F I G U R E  2  Content of water and Na+ in cortex, medulla and papilla. (A) The wet and dry weight of similarly sampled tissue blocs from 
papilla of Wt or Epac1−/− mice. (B) The water content (%) in consecutively sampled tissue blocks from cortex, medulla and papilla. (C) The sodium 
concentration in consecutively sampled tissue blocs from cortex to papilla in Wt and Epac1−/− mice. The values shown are mean (SD), n = 4 Wt 
mice and n = 11 Epac1−/− mice. Unpaired two-tailed Student's t test (A) wet weight, P = .35 and dry weight, P = .86 or two-way ANOVA with 
Sidak's adjustment for multiple comparisons (B) F(1, 39) = 5.717, *P = .0217 and (C) F(1, 39) = 42.1, ‡P < .001 was used to determine statistical 
differences between Wt and Epac1−/− mice
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and blindly scored by independent operators (Table S4; see also 
Figure 5). The median value for this parameter was 0 for Wt and 
38% for Epac1 null mouse TJs (Table S4).
The ICs have been reported to have very high28 or quite 
low29 Epac1 expression. We found that intercalated/principal 
(IC/PC) TJs were longer and more electron dense than PC/
PC TJs, and less affected by Epac1 deletion (Figure S4A-C, 
Table S5) than those in the PC/PC paracellular space (Table 
S4).
2.6 | Epac1−/− mice have intact glomerular 
filtration barrier and moderately elevated GFR
Rodent glomeruli have high Epac1 mRNA expression,6 sug-
gesting that Epac1 has a functional role in the glomerulus. We 
probed this possibility, first by testing whether Epac1−/− mice 
could have a defect glomerular filtration barrier, a dysfunc-
tion of which would cause increased albumin leakage.30,31 
We found similar levels of albumin in Wt and Epac1−/− mice 
urine, and whether the mice had been treated with dDAVP or 
not (Figure 7).
We considered next if Epac1 could control the GFR, pos-
sibly by modulating the TGF loop at the glomerular end. This 
possibility was tested by comparing the renal clearance of 
creatinine and of [14C]inulin in the absence and presence of 
the TGF-blocking agent furosemide. To know if the primary 
furosemide target (NKCC2 of the macula densa) was intact 
in Epac1−/− mice, we compared first the effect of furosemide 
on Wt and Epac1 null mouse diuresis and Na+ excretion.
We found that Wt and Epac1−/− mice had similar furose-
mide-induced diuresis and Na+ excretion (Figure 8A,B). The 
furosemide-treated Wt and Epac1−/− mice had also similar 
clearance of creatinine and inulin (Figure 8C,D). In the ab-
sence of furosemide, the Epac1−/− mice had increased clear-
ance of creatinine, inulin and cAMP under both basal and 
dDAVP-stimulated conditions (Figure 8C,D; Table 3, Figure 
S5A,B).
F I G U R E  3  The osmolarity of antidiuretic urine from Wt and 
Epac1−/− mice. The figure shows at left the concentration of urea 
and at right the (actual) osmolarity of urine from overnight water-
restricted Wt (black symbols) or Epac1−/− (blue symbols) mice. In 
the middle, the urea concentration + 2× the sum of the determined 
cation concentrations (sodium + ammonium +potassium + calcium 
+magnesium) is shown. The values are mean, n = 4 for Wt mice and 
n = 11 for Epac1−/− mice. Two-way ANOVA with Sidak's adjustment 
for multiple comparisons, F(1, 34) = 287.2, ‡P < .001, was used to 





































F I G U R E  4  The renal content of 131I-albumin (iv injected at −5 min) and 125I-albumin (iv injected at −35 min). (A) The content of 131I-HSA 
per mg dry weight of kidney removed 5 min after the intravenous injection of 131I-HSA. Each group comprised 10 animals, for each of which both 
the right and left kidney were analysed. A horizontal line indicates the median value. (B) The difference between the renal 125I-HSA and 131I-HSA 
content of mice injected 35 min earlier with 125I-HSA and 5 min earlier with 131I-HSA. The values shown are mean (SD). One-way ANOVA with 
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3 |  DISCUSSION
Our observation that Epac1 null mice have nephrogenic 
diabetes insipidus (Table 1A, Figure 1) with lowered papil-
lary Na+ content (Figure 2C) and shorter and less dense CD 
TJs (Table S3, Figures 5 and 6) conforms to the hypoth-
esis that the primary Epac1-dependent antidiuretic mecha-
nism is to control the leakiness of the intercellular junction 
between CD PCs. Possible Epac1-dependent mechanisms 
modulating transcellular water and urea transport or glo-
merular filtration appear to be less significant to explain 
the diabetes insipidus phenotype. These observations pro-
vide new understanding of the biological significance of 
high renal Epac1 expression.6-8 We discuss the possible 
Epac1-dependent mechanisms suggested in the introduc-
tion in more detail below.
The diuretic phenotype with decreased conservation of 
free water (Figure 1C) is a hallmark of deficient AVP action 
in the CD.23,32 We tested several mechanisms that could lead 
to decreased AVP-mediated water conservation. We found no 
evidence that Epac1−/− mice have a subresponsive Avpr2 re-
ceptor or excessive degradation of cAMP. The renal cAMP 
excretion after a general dDAVP stimulation increased at least 
as much in Epac1−/− as in Wt mice (Figure 1D). The secre-
tory component (clearance—GFR) for cAMP was similar in 
Wt and Epac1−/− mice (Figure S5B), implying that Wt and 
Epac1−/− mice have similar renal excretion of cAMP. The 
apparent cAMP resistance of Epac1−/− mice to AVP effects 
F I G U R E  5  The ultrastructure of 
typical CD tight junctions from Epac1−/− 
and Wt mice. (A, C, E) Junctions from three 
Epac1−/− mice with near median TJ length 
and electron density. The morphometric data 
for each of the sections are found in Table 
S4, where they are highlighted in blue and 
marked with *. (B, D, F) Junctions from 
three representative Wt mice, highlighted in 
yellow and marked with * in Table S4. CD, 
collecting duct
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was, therefore, not explained by increased cellular cAMP 
extrusion.
The CD and connecting tubule  (CNT) segments of the 
nephron have the highest expression of both Epac1 (RapGef3) 
and AVP receptor 2 (Avpr2), while the short (SDL) and 
long (LDLIM) descending limb and tAL segments of the neph-
ron have moderate Epac1 (RapGef3) expression and no appre-
ciable Avpr2 expression (Ref. 6 Table S3). Thus, Epac1 is likely 
to be activated by AVP mainly in the CD and CNT segments.
The action of Epac1 in the cAMP-stimulated CD could be 
to augment the known PKA-mediated actions such as induc-
tion or membrane insertion of aquaporins 2, 3 or UT-A1/3 
or UT-A2.5,13 Although Epac1 has been reported to promote 
AQP-2 expression upon long-term cAMP stimulation,14 nei-
ther the Aqp-2 transcript nor the protein level differed be-
tween Wt and Epac1 null mice (Figure S3B-D). Thus, direct 
Epac1-dependent regulation of AQP-2 expression is unlikely 
to account for the diuretic state.
The diuretic Epac1−/− phenotype was not explained by 
deficient urea transport, since it was more severe at low (4%) 
than high (40%) protein diet (Table 2), and not associated 
with altered expression of the UT-A1/3 urea transporter 
(Figure S3A). A lack of Epac1 does, therefore, not lead to 
diet/urea-induced osmotic diuresis in contrast to the expecta-
tion from an in vitro study13 reporting Epac1 enhanced UT-
A1/3 urea transporter expression.
Overnight water-deprived Epac1−/− mice had not only a 
more dilute bladder urine than Wt mice (Figure 3), but also 
a similarly decreased renal medullary Na+ and presumably 
osmotic gradient (Figure 2C). Epac1 therefore appears to 
be required to maintain a steep medullary osmotic gradient 
to prevent water loss under antidiuretic conditions. A simi-
lar osmotic gradient deficiency was observed in mice with 
lowered CD paracellular TJ resistance due to CD-specific 
deletion of the transcription factor GRHL2.26 The similar 
decrease of Na+ and osmolarity in the renal papilla and 
urine in GRHL2- and Epac1-targeted mice (26 and Figures 
2 and 3), as compared to Wt mice, argues that water can 
F I G U R E  6  The CD tight junctions are shorter and less dense in Epac1−/− than in Wt mice. (A) Histograms of the TJ length of Wt and 
Epac1−/− collecting duct PC/PC junctions. (B) Histogram of the average central electron transmission, determined along the entire length of each 
tight junction. (C) Histogram of the average TJ ‘mass’. The central electron transmission (B) is the average value observed along the central region 
of the TJ divided by the transmission in the collecting duct lumen. The TJ ‘mass’ is the TJ area × the average TJ electron absorbance (see Materials 
and Methods section for details). Values are shown as mean (SD) and mean (SEM), n = 6 Wt mice and 5 Epac1−/− mice. A total of 56 Wt TJs and 
51 Epac1−/− mouse junctions were analysed. Details of statistics used: Two-tailed Mann-Whitney test (A) Sum of ranks 4112, 1666, Mann-Whitney 
U = 340, ‡P < .001, (B) sum of ranks 1762, 4016, Mann-Whitney U = 166, ‡P < .001 and (C) sum of ranks 4126, 1652, Mann-Whitney U = 326, 
































































F I G U R E  7  Urinary albumin excretion. Albuminuria, expressed 
as the urine albumin/creatinine ratio, is shown for Wt (n = 4) and 
Epac1−/− (n = 4) mice given vehicle or dDAVP. The urine was 
collected for 6 h after WL (see Figure 1 for details of method). The 
values shown are mean (SD). Solid thin lines show the average for 
vehicle- and dDAVP-injected mice. Unpaired two-tailed Student’s t 
test with Welch’s correction and unpaired two-tailed Student’s t test, 
P = .16 for WL vehicle and P = .75 for WL dDAVP was used to 

























Wt WL vehicle (0-6 h)
Epac1–/– WL vehicle (0-6 h)
Wt WL dDAVP (0-6 h)
Epac1–/– WL dDAVP (0-6 h)
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equilibrate between the papillary tissue and the pre-urine 
in the CD lumen. Such equilibration would not be expected 
if Epac1 were critically required for aquaporin synthesis 
or insertion. In line with the observation above, there was 
no difference between Epac1−/− and Wt mice regarding 
AQP-2 expression (Figure S3).
Isolated GRHL2-deficient PC cells have severely de-
creased paracellular electrical resistance.26 This observation 
provides a link between paracellular ‘leakage’ and the in vivo 
phenotype of decreased papillary osmotic gradient and in-
creased diuresis,26 but it does not tell if the PC TJ permeabil-
ity can be under physiological control.
We found that the PC/PC TJs were less electron-dense 
and had less associated junctional material in Epac1−/− 
than Wt mice (Figures 5 and 6; Table S4). Epac1 is well 
known to tighten JCs, both in vitro (see Ref. 25 for recent 
review) and in vivo.7 It may also mediate the cAMP-in-
duced stabilization of the retinal blood brain barrier TJs.33 
The simplest explanation of the present Epac1 null mouse 
diuretic phenotype is, therefore, that Epac1 maintains the 
corticopapillary osmotic gradient by strengthening the CD 
paracellular TJs.
The diuretic Epac1−/− phenotype described here, and 
preliminarily reported,9 is characterized by dilute urine 
under antidiuretic conditions, as well as near unaltered 
Na+ excretion (Table 2). Therefore, it differs strongly 
from the recently described Epac1−/− osmotic diuresis 
phenotype, caused by increased Na+ excretion ascribed 
to decreased proximal tubule (PT) expression of the so-
dium-hydrogen exchanger 3.34,35 Although a PT-localized 
primary phenotype is plausible in view of an early study 
showing strong immunohistochemical staining for Epac1 
in the PT brush border,28 it is not supported by more re-
cent quantitative mRNA expression data, which show in-
significant RapGef3 expression in the PT (Table S3, 6). 
There is no obvious explanation for the dramatic difference 
of renal phenotypes between the two RapGef3 ‘knock out’ 
mice. The mice used in the present study have increased 
F I G U R E  8  The effect of furosemide on diuresis, Na+, creatinine and inulin clearance. (A, B, C) Wt (n = 11) and Epac1−/− (n = 11) mice 
were water loaded (see Figure 1A for details), and the urine collected continuously for 3 h. Four days later, the water loading (WL) was repeated, 
combined with furosemide injection. The effect of furosemide is shown for (A) diuresis, (B) Na+ excretion rate, n = 3-4 mice/group, P = .19 for 
vehicle and P = .47 for furosemide. (C) The creatinine clearance of Wt (n = 10-14) and Epac1−/− mice (n = 10-13) during the first 6 h after WL, 
with or without a concomitant furosemide injection, *P = .022 for vehicle and P = .40 for furosemide. (D) The effect of furosemide on inulin 
clearance (for four pairs of vehicle or furosemide treated Wt and Epac1−/− mice), †P = .0017 for vehicle and P = .22 for furosemide. Values are 
mean ± SEM (A) or mean (SD). Unpaired two-tailed Student’s t test was used for statistics, except for panel (C) where the paired two-tailed 
Student’s t test was used. For further details, see Materials and Methods
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microvascular permeability, as would be expected based 
on extensive in vitro studies on endothelial cells with 
downregulated Epac1 activity (see review Ref. 25). 
Further, endothelial cells isolated from the Epac1−/− mice 
used here have increased junctional permeability when 
monolayers are tested in vitro36 implying that the perme-
ability phenotype is caused by the lack of Epac1 in the en-
dothelial cells and not by an altered in vivo environment 
in the Epac1−/− mice.
The high RapGef3 mRNA expression in rat glomeruli6 
suggests that Epac1 can impact glomerular functions. Epac1 
appeared not to be required to maintain an intact glomerular 
filtration barrier since the Epac null mice did not have albu-
minuria (Figure 7).
The Epac1 null mice had increased clearance of creatinine 
and cAMP (Table 3, Figure 8C and Figure S5), which could 
be explained either by increased tubular excretion37,38 or in-
creased GFR. The lower [14C]inulin clearance of Wt than 
Epac1−/− mice, in the absence, but not in the presence, of the 
TGF inhibitor furosemide (Figure 8D) suggests that Epac1 
may restrain the GFR via TGF modulation.
In conclusion, Epac1 appears to prevent diabetes insip-
idus mainly by maintaining the corticomedullary osmotic 
gradient. This may at least in part be achieved through Epac1-
mediated control of paracellular CD ‘leakage’.
4 |  MATERIALS AND METHODS
4.1 | Reagents
Creatinine, dDAVP and furosemide were obtained from 
Sigma-Aldrich. 14C-inulin (1  mCi) was from Perkin-Elmer 
(Cetus) and was diluted with unlabelled inulin (from chicory, 
Sigma-Aldrich) before being used for experiments in a con-
centration of 2.1  mCi  mL−1. Ultracel-30 membrane filters 
(cut-off = 30.000 kDa) were from Millipore.
4.2 | Ethical approval
The animal experiments were approved by the Norwegian 
Animal Research Authority and conducted according to the 
European Convention for the Protection of Vertebrates Used 
for Scientific Purposes, Norway. These regulations comply 
with the UK policies and regulations.39 The Animal Care 
T A B L E  3  Key urinary and plasma parameters for Wt and Epac1−/− mice on normal chow given 1.5-mL water load (WL) ± dDAVP
Variable determined
WL + vehicle, day 1 dDAVP injection day 7
WT Epac1−/− WT Epac1−/−
Urine output (mL 6h−1) 2.16 (SD0.16) 2.59 (SD0.29)aa 1.02 (SD0.32) 1.41 (SD0.33)
Diuresis—loaded H20 (µL g
−1) 29.5 (SD4.9) 46.4 (SD12)b −22.8 (SD16) −3.41 (SD14)
Urine osm. (mOsm kg−1 H2O) 223 (SD40) 256 (SD21) 599 (SD143) 441 (SD92)
Urine urea (mmol/L) 126 (SD24) 124 (SD23) 275 (SD76) 211 (SD56)
Urine Na+ (mmol/L) 39.1 (SD6.7) 45.1 (SD3.4) 76.4 (SD35) 48.4 (SD15)
Urine K+ (mmol/L) 19.9 (SD3.9) 23.0 (SD4.6) 51.5 (SD20) 35.6 (SD12)
Urine creatinine (μmol/L) 331 (SD74) 332 (SD44) 961 (SD271) 864 (SD328)
Urine cAMP (μmol/L) 3.15 (SD1.03) 4.44 (SD0.54)c 5.91 (SD0.83) 8.35 (SD2.36)g
nosm (excr. min−1 g−1) 60.3 (SD7.7) 78.2 (SD4.7)ddd 75.4 (SD6.1) 70.0 (SD7.7)
nmol Urea (excr. min−1 g−1) 34.0 (SD5.4) 37.7 (SD6.1) 34.8 (SD5.3) 34.1 (SD8.4)
nmol Na+ (excr. min−1 g−1) 2.65 (SD0.38) 3.49 (SD0.67) 9.60 (SD4.2) 8.06 (SD2.3)
nmol K+ (excr. min−1 g−1) 1.34 (SD0.21) 1.75 (SD0.32) 6.39 (SD1.5) 5.56 (SD0.97)
pmol creatinine (excr. min−1 g−1) 92.4 (SD15) 101 (SD5.7) 125 (SD22) 140 (SD45)
Plasma urea (mmol/L) 11.2 (SD0.0) 10.5 (SD0.0) 10.8 (SD1.8) 10.2 (SD2.4)
Plasma creatinine (μmol/L) 7.9 (SD0.4) 6.7 (SD0.7)ee 5.70 (SD1.1) 5.72 (SD1.5)
Plasma cAMP (nmol/L) 60.9 (SD4.4) 63.1 (SD1.7) 69.9 (SD5.0) 59.7 (SD8.0)
Urea clearance (μL min−1) 67.6 (SD15) 84.9 (SD17) 66.8 (SD18.0) 84.8 (SD21.1)
Creatinine clearance(μL min−1) 243 (SD69) 353 (SD34)ff 472 (SD18) 557 (SD159)
Wt (n = 6) and Epac1−/− mice (n = 6) were water loaded (1.5 mL) and injected with 0.1-mL saline. Thereafter, the urine collected for 6 h, when blood was sampled for 
plasma analysis. One week later, the same mice injected with dDAVP instead of saline. Data are mean (SD) and excretion data are normalized per g body weight. The 
statistical significance was judged by unpaired Student’s t test with Welch’ correction when applicable, either for vehicle-treated (aaP = .0096, bP = .0114, cP = .022, 
dddP = .0007, eeP = .0037, ffP = .0056) or dDAVP-treated animals (gP = .038).
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and Use Programs at University of Bergen are accredited by 
AAALAC international.
4.3 | Targeted disruption of the Epac1 gene 
to produce C57BL/6J Epac1−/− mice
The C57BL/6JBomTac mouse strain is described at http://
www.tacon ic.com/wmspa ge.cfm?parm1 =764. Epac1 null 
(Epac1−/−) mice were generated using the Cre-LoxP sys-
tem as described previously.7,40,41 In short, loxP sites were 
inserted by homologous recombination into the gene en-
coding Epac1 (RapGef3) flanking exons 7-10. These exons 
encode the CBD-B domain, which codes for the only func-
tional cAMP site of Epac1.42,43 In addition, a frame shift 
was introduced distal to the deletion in order to minimize 
the probability of expression of truncated Epac1 fragments 
through unscheduled translation. C57BL/6JBomTac mice 
from Taconic, Denmark were used to backcross the recom-
bined chimeric mice for at least 10 generations. The stabil-
ity of the deletion was confirmed by genotyping for each 
new generation.
4.4 | General animal handling
The mice used in the present study were about 3-4 months old 
females, weighing 18-30 g. The wild-type C57BL/6J BomTac 
mice (Wt) and their Epac1 null counterparts (Epac1−/−) were 
littermates, or they were born and kept in neighbour cages 
of the Epac1−/− mice. They were generally housed 4-5 mice 
together in IVC-II cages (Sealsafe® IVC Blue Line 1284L, 
Tecniplast) and maintained under standard housing conditions 
at 21°C ± 0.5°C, 55% ± 5% humidity, 12-hours artificial light-
dark cycle (150 lux). The Epac1 null mice had the same weight 
as their Wt littermates, from which they were indistinguishable 
F I G U R E  9  Overview of the experiments conducted to test the effect on urine production and composition of protein diet, dDAVP and 
furosemide. A, Mice were fed low (4%) protein diet for 7 d and the urine sampled for 24 h thereafter. One day later, the mice received an acute 
per-oral (p. o.) intubation of 1.5-mL water, and the urine was collected continuously (as voided) for 6 h thereafter. The animals were next switched 
to high-protein (40%) diet, and 7 d thereafter, subjected to the same experiments as when fed low-protein diet. B, Mice fed standard (12.5%) protein 
diet were transferred to metabolic cages and their urine collected for 24 h under basal conditions. Seven days later, the mice received a 1.5-mL 
water load (WL) and 0.1-mL saline i.p., and their urine was collected continuously for 6 h thereafter. The experiment was repeated after 7 d, but 
with injection of dDAVP instead of saline. C, Mice, inserted sc. on the back 3 d previously with a mini-osmotic pump loaded with [y14C]inulin, 
were water loaded as described above, and the urine collected for 3h. Two days later, the experiment was repeated, but with a furosemide injection 
at the time of water loading
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based on visual observation under standard housing conditions. 
The Wt and Epac1 null mice had also similar blood pressure.7
For most experiments, the mice were provided with stan-
dard rodent chow containing 12.5% protein (Special Diet 
Services RM1, 801151, Scanbur BK) and water ad libitum. 
For experiments designed to manipulate the standard urea 
load, the animals received low (4%) protein or high (40%) 
protein chow from Custom Diet Services, Special Diet 
Services, Witham, UK. Since most experiments were con-
ducted in single-housed metabolic cages, each animal was 
acclimatized for 24 hours in a metabolic cage for 3-4 days 
before the onset of each experiment.
Anaesthesia was with 1.5%-2% Isoba® vet. Isoflurane 
(Schering-Plough Animal Health) under continuous flow of 
O2 (1 L m
−1) and N2O (1 L m
−1). The anaesthetized animals 
were placed on a heating pad at 37°C to limit any drop of 
the body temperature. The dDAVP (1-ng g−1 body weight) 
or furosemide (40-µg g−1 body weight) was injected intraper-
itoneal (i.p.) in 0.1-mL 150-mmol/L aqueous saline (NaCl) 
solution during anaesthesia shortly before the intragastric in-
tubation with 1.5-mL water (see Figure 9 below for details). 
Cardiac blood (0.4 mL) was aspirated into a 0.5-mL syringe 
with 0.1-mL citrate-dextrose solution by cardiac puncture of 
animals killed with CO2, and thereafter centrifuged for 3 min-
utes at 500 rpm to yield plasma. Plasma samples were stored 
at −80°C and urine samples at −20°C for further analysis.
The animals showed no symptoms of distress or ill-
ness during the experiments. Two Epac1−/− mice appeared 
debilitated during a 24-hours pre-experimental stay in 
metabolic cages. They were therefore excluded from any 
experiment. Two mice (one Wt and one KO) had badly fit-
ted drinking bottles during the 24-hours experiment, result-
ing in contamination of urine. They were excluded from 
that experiment, but not from the subsequent water-loading 
experiments.
4.5 | Overview of the major animal 
experiments conducted
4.5.1 | Urine collection and WL
In one series of experiments, the urine of animals given chow 
with various protein content was collected for 24 hours via a 
tube connected to the funnel-shaped bottom of the metabolic 
cage. The experiments were conducted in individual MMC10 
metabolic cages (Hatteras Instruments, Inc) and started at 
09.00 am. The urine bladders were emptied by bladder mas-
sage immediately before placing the animals in the metabolic 
cages.
In another series, each mouse was anaesthetized just 
after the bladder had been emptied, and then subjected 
to acute water loading (WL, 1.5-mL H2O) by intragastric 
intubation through a 38-mm metal gavage with a silicon 
tip (AgnTho's AB), and placed in a metabolic cage. The 
urinary bladder was emptied by external massage before 
the urine was collected (see Materials and Methods and 
legend to Figure 9 for further details). In this way, errors 
caused by individual differences of recent water intake and 
residual urine content were minimized. The urine that was 
spontaneously voided thereafter was collected into a sili-
conized beaker and manually recovered by pipetting. The 
volume of each recovered urine sample was determined, 
before adding it to a pre-weighed tube. The sum of the vol-
umes determined fit well with the weight increase of the 
collecting tube.
4.5.2 | Experiments using high protein diet-
induced urea loading
To test the ability of the mice to handle urea loading, they 
were first fed low protein diet for 1 week in ordinary cages, 
and thereafter for 24 hours in individual metabolic cages. The 
mice were next water loaded as described above, returned to 
the metabolic cage and the urine voided was collected dur-
ing a period of 6 hours. Thereafter, 0.2-mL whole blood was 
collected from a puncture in the facial vein for analysis of 
serum creatinine and urea. The next week, the same mice 
were switched to high protein diet, and thereafter treated as 
described for the low protein fed mice.
4.5.3 | Determination of GFR and 
microvascular permeability
The GFR was determined as the renal clearance of [14C]inu-
lin as described in,44 except that the infusion pumps (Alzet® 
osmotic minipump model 1007D, DURECT Corporation) 
were placed subcutaneously between the withers rather 
than intraperitoneally. Each pump was filled with 25 μCi 
[14C]inulin in 150-mmol/L aqueous saline (NaCl) solution, 
and delivered 0.5  ±  0.1  μL  h−1. They were primed over-
night in the 0.9% saline solution at 37°C. Experiments were 
conducted at least 2  days after pump implantation. The 
amount of [14C]inulin was determined in the urine and in 
whole blood collected from the facial vein in 10-μL capil-
lary pipettes (Minicaps, Hirschmann-Laborgeräte). For ter-
minal experiments, the blood (2 × 50 μL) was collected by 
heart puncture. Samples of urine (10 µL), plasma (28 µL) 
or whole blood (50 µL) were mixed thoroughly with 1-mL 
2% SDS (20  g  SDS  L−1) and next with 10-mL scintilla-
tion liquid (Emulsifier-safe™, Perkin-Elmer, Inc) before 
being counted in Tri-Carb 2900TR Liquid Scintillation 
Analyzer (Perkin-Elmer, Inc). To minimize any non-spe-
cific chemiluminescence, the vials were left for 1  day in 
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the dark before starting the counting, and each vial was 
counted 3 × 10 minutes. The counting efficiency of [14C]
inulin was determined by recounting each vial after a small 
volume with a known high [14C]inulin concentration had 
been added to each vial.
A previous study comparing Wt and Epac1−/− mice7 
showed that Epac1 and ANP acted oppositely on the micro-
vascular permeability for albumin in tissues like skin, fat, 
muscle and intestine, with known capacity to store excess in-
travascular fluid. Similar data for the kidney were obtained, 
but not reported. They are reported here since they could tell 
whether Epac1 deletion or ANP affects the extravascular 
renal accumulation of serum albumin. The mice were anaes-
thetized with 1.5%-2% isoflurane in air (Isoba vet, Schering-
Plough Animal Health) administered through a nose cone. 
Human serum albumin (HSA) labelled with either 125I or 131I 
was injected sequentially in the jugular vein, respectively, 35 
and 5 minutes prior to termination of the experiment. Blood 
samples were obtained before the mice received a lethal iv 
injection of saturated KCl, and tissue samples harvested. The 
right and left kidneys were removed, rinsed for blood, the 
radioactivity determined and spillover from 131I to 125I cor-
rected for. The kidneys were dried until stable dry weight was 
obtained. Distribution volumes were determined as plasma 
equivalent volumes (ie cpm per g tissue divided by cpm per 
mL plasma obtained at the end of the experiment for each 
mouse) and referenced to dry tissue weight. For further de-
tails, see Ref. 7.
4.6 | Determination of the 
osmolarity and the concentration of 
NaCl and selected other ions in the renal 
papilla interstitium and in bladder urine
Eleven female Epac1−/− mice and four Wt mice, deprived 
of drinking water overnight (total 10  hours), were anaes-
thetized with 1.5% isoflurane (IsoFlo®Vet 100%, ABBOT 
Laboratories Ltd) in 100% O2. Bladder urine was collected 
by suprapubic puncture and collected in Eppendorf tubes for 
measuring osmolarity (Wescor vapor pressure osmometer 
model 5600) and the concentration of urea (mixed-mode 
chromatography) and cations (ion chromatography). Blood 
was collected by heart puncture and both kidneys were then 
rapidly removed through a midline incision and snap-frozen 
in Eppendorf tubes in liquid nitrogen. The kidney poles of 
the shock-frozen kidneys were cut-off perpendicularly to the 
long axis with a scalpel. The remaining central 2- to 3-mm 
thick tissue block containing the papilla was then imme-
diately dissected on a chilled glass plate into a pyramidal-
shaped tissue block with the papillary tip as the apex and the 
cortex as the basis. From this block, three consecutive tissue 
samples were cut-off while still semi-frozen separating the 
pale papilla from the darker medulla and cortex from the re-
maining medulla.
The tissue samples were immediately transferred into 
pre-weighed Eppendorf tubes, weighed and dried at 40°C 
for estimation of water content. The dried tissue samples 
were then equilibrated in 500-µL Milli-Q water in the same 
Eppendorf tubes for at least 3 days to measure total tissue 
cation content. Sodium, ammonium, potassium, magne-
sium and calcium in diluted urine (1:201), plasma (1:101) 
and undiluted eluate from renal papilla, medulla and cor-
tex were baseline separated in a 10 minutes 7.5-60 mmol/L 
MSA gradient by a Dionex IonPac CS 12A analytical col-
umn (8.5  μm, 2  ×  250  mm, P/N 046075) at a flow rate 
of 0.2  mL  min−1 using a Dionex Integrion HPIC System 
equipped with a CDRS 600 (2  mm) Cation Electrolytic 
Suppressor and a high pressure EGC 500 methane sul-
fonic acid eluent generator cartridge. Urea in urine was 
separated in an acetonitrile-water gradient using a Thermo 
Scientific™ Acclaim™ Trinity P2 column (100 mm, cat-
alogue number 085434) connected to a Thermo Scientific 
UltiMate 3000 Rapid Separation system and detected by a 
Corona Veo Charged Aerosol Detector.
4.7 | Laboratory methods
Urinary and plasma cAMP was determined as described 
previously.45,46 The urea concentration in urine was deter-
mined by the QuantiChrom™ Kit (DIUR-500; Bio-Assay 
systems) according to manufacturer's protocol. To achieve 
accurate determination of urea in mouse plasma, the sam-
ples were diluted fivefold in H2O and partially deprotein-
ized by spinning through Ultracel-30kDa membrane filters 
(Millipore), before being assayed. Osmolality was deter-
mined using a Wescor 133 vapor pressure osmometer with 
SS-033 filter discs (Wescor Inc) according to the manufac-
turer's protocol. Urine Na+ and K+ were determined using 
ion-selective electrodes (analysed by the Laboratory for 
Clinical Biochemistry at Haukeland Hospital in Bergen, 
Norway).
Creatinine in urine was determined either by an enzymatic 
creatinase assay (CREA Plus kit; Boehringer Mannheim), 
using a Roche Cobas Bio Analyzer (Roche) or based on 
HPLC.20 Only the latter method, with the modifications de-
scribed below, produced reliable determinations in mouse 
plasma. Briefly, plasma samples (20 μL) were deproteinized 
by adding 2-mL acetonitrile, vortexed and centrifuged for 
15 minutes at 13 000 g at 4°C. After evaporation to dryness, 
the samples were dissolved in 120 µL of 5-mmol/L sodium 
acetate, pH 5 (HPLC mobile phase), and 15 µL of 20 000×g 
supernatant injected into a 100 × 1.45-mm PRP-X200 cation 
exchange column (Hamilton) equilibrated with HPLC mobile 
phase to separate creatinine, which is positively charged at 
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pH 4.68, from acidic interfering compounds. By switching to 
10-mmol/L potassium buffer (pH 7.10) in the second-dimen-
sion column (Proswift SCX-1S, 4.6 × 50 mm, Dionex), the 
creatinine molecule was neutralized, resulting in a reduced 
retention and a sharp, well-defined peak detected at its ab-
sorption maximum of 234. The specificity of the method was 
validated by the analysis of urine and plasma samples before 
and after treatment at 25°C overnight with 90 U mL−1 creati-
ninase (EC 3.5.2.10, 1000 U) and 50 U mL−1 creatinase (EC 
3.5.3.3, 500U).
Albumin from 10-µl urine was determined by 2D-HPLC 
using size-exclusion chromatography (Super SW2000, 
4.6  ×  300  mm, Tosoh Bioscience) in the first dimen-
sion and reversed phase chromatography (Proswift Rp4H 
1 × 50 mm, Dionex) in the second dimension. The albu-
min from the first-dimension column was automatically 
loaded onto the second-dimension column at a flow rate 
of 0.35 mL min−1 by an inline switch. Albumin was then 
separated from proteins with similar molecular weight by 
an 8-minute acetonitrile gradient (5-60%). The albumin 
concentration was determined based on the area under the 
curve for standards and samples.47
The relative Aqp-2 and UT-A1/3 mRNA levels were de-
termined by quantitative qRT-PCR. Total RNA was isolated 
from whole kidneys from WL (+3  hours) and WL/dDAVP 
(+6 hours) Wt and Epac1−/− mice using the TRIzol reagent 
according to the manufacturer’s protocol. 1.5  μg RNA was 
converted to cDNA using 0.75 μmol/L random hexamer and 
1.5 μmol/L Oligo-dT primer, 1-mmol/L dNTP-mix and 50 U 
RevertAid Reverse Transcriptase (Thermo Scientific). The 
RT-PCR reaction was carried out on MJ Research PTC-200 for 
four cycles at 25°C for 10 minues, 42°C for 60 minues, 70°C for 
10 minues and 4°C ‘forever’. The qPCR was on a LightCycler 
480 II (Roche) with cDNA corresponding to 5.5 ng RNA and 
SYBR Green Supermix (BioRad) with one 300 seconds cycle 
at 95°C, 40 cycles of 10 seconds at 95°C, 10 seconds at 60°C 
and 20 seconds at 72°C followed by a melting curve analysis. 
All results are average of two separate experiments, each in 
triplicate. Expression levels were related to the sample (total) 
RNA concentration as well as to the geometrical mean con-
centration of the assumedly stably expressed (‘household’) 
mRNA’s coding for succinate dehydrogenase complex subunit 
alpha (SDHA), Peptidyl-prolyl cis-trans isomerase A (Ppia) 
and cGMP-dependent protein kinase (Pkg1), and relative gene 
expression estimated using the 1.8−ΔΔCt method. The primer 
sequences for: AQP-2; fwd: GCCCTGCTCTCTCCATTG, rev: 
TCAAACTTGCCAGTGACAAC, for UT-A1; fwd: CTGCCA 
CCTGGGCTTCTTTTG, rev: GGGTAACGCCTGAGAGA 
CAAG, for SDHA; fwd: CATGCCAGGGAAGATTACAA, rev: 
GCACAGTCAGCCTCATTCAA, for Ppia; fwd: TGAGCACT 
GGAGAGAAAGGA, rev: CCATTATGGCGTGTAAAGTCA 
and for Pkg1; fwd: TGGATGACGTTTCCAACAAA, rev: 
CACTATGTGGCGCTTCTTGA.
Immunoblotting of AQP-2: For this, 100  µg of whole 
kidney extracts in RIPA buffer containing cOMplete™ Mini 
Protease Inhibitor Cocktail (Roche Diagnostics GmbH) was 
separated by 4%-12.5% (w/vol) SDS/PAGE and transferred to 
Hybond™ P 0.45 μm PVDF membrane (GE Healthcare Life 
Sciences, Buckinghamshire, UK) using rabbit anti-AQP-2 
(1:3000 in PBS-T o/n) as primary antibody and alkaline phos-
phatase-conjugated goat anti-rabbit IgG (1:10 000 in PBS-T, 
1  hour RT, A3687, Sigma-Aldrich) as the secondary anti-
body. Prof. Robert A. Fenton, University of Aarhus, Denmark 
kindly provided the primary antibody. The membranes were 
incubated in 100-mmol/L aqueous diethanolamine with 
100-mmol/L MgCl2 pH 9.5 for 2 × 2 minues before the blots 
were developed with ECL using CDP-Star® Chemiluminescent 
Substrate (Tropix) and evaluated with the Luminescent Image 
Analyzer LAS-3000 (Fujifilm). Relative intensity of the bands 
was quantified and normalized to a loading control (β-actin) 
using the software Multi Gauge volume 2.3.
Haematoxylin and eosin (H&E) staining: Formalin-fixed, 
paraffin-embedded kidney sections (4  µm) were stained with 
H&E as described in.48 Kidney histology was visualized by 
light microscopy (Leica, DMLB) and analysis Pro. 3.2 software 
(Leica). Images 10x-20x was taken using a Leica DC300 camera.
The TEM study was performed essentially as described ear-
lier.7 Briefly, kidney medulla tissue was pre-fixed in 2% glutar-
aldehyde in 0.1 mol/L Na-cacodylate buffer o/n at 4°C, washed 
3 × 30 minues in 0.1 mol/L Na-cacodylate buffer and post-
fixed for 2 hours in 1% OSO4 in 0.1 mol/L Na-cacodylate buf-
fer at 4°C. The samples were then washed for 3 × 30 minues in 
0.1 mol/L Na-cacodylate buffer, dehydrated in a graded alco-
hol series and embedded in a graded 1.2 Propylene oxide/Agar 
100 Resin series, ending with pure Agar 100 Resin o/n at RT. 
After 48 hours curing at 60°C, ultrathin sections (55-60 nm) 
were stained with uranyl acetate and lead citrate. The mounted 
samples were studied in a JEOL JEM-1230 TEM (JEOL Ltd), 
at the Molecular Imaging Center at UoB.
4.8 | Morphometric analysis of CD 
paracellular junctions
The electron micrographs of the renal medulla CD para-
cellular apical TJ and its adjoining JC were analysed for 
length, area and density using the ImageJ software (vers. 
2.0; https ://imagej.net) The average pixel density was de-
termined for the central 12-18  nm of the (apical) TJ and 
the central 18-24 nm of the adjoining JC. We determined 
also the average pixel density for the whole area of each 
TJ and JC, including their attached electron-dense material, 
which was clearly demarcated from the ordinary cytoplasm 
and therefore easy to delineate. Since the overall exposure 
varied between the micrographs, the junctional pixel den-
sity (a) was adjusted for the pixel density in the CD lumen 
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(b). The parameter ‘el.transm’ in Table S4 is therefore a/b 
(TJ pix. dens./CD lumen ‘background’ pix. dens). The sub-
jective estimation of TJ ‘openness’ was assessed by two 
independent persons. All sections were evaluated blindly.
4.9 | Graphic illustration and 
statistical analysis
Excel 2014/2017 (Microsoft Corporation) and GraphPad 
Prism 6.0 (Graph-Pad Software) were used for statistical 
calculations and graphic illustrations. Data sets are generally 
presented as mean (SD) and mean (SEM). For comparison 
of variables in littermate animals relative to the Epac1−/− 
animals, statistical significance was assessed by either of 
the following tests: the unpaired two-tailed Student’s t test 
with Welch’s correction (when applicable), the paired two-
tailed Student’s t test, the one-way ANOVA with Dunnett's 
adjustment for multiple comparisons, two-way ANOVA with 
Sidak’s or Tukey's adjustment for multiple comparisons, the 
Kruskal-Wallis test with Dunn’s multiple comparisons test, 
the two-tailed Mann-Whitney test or Wilcoxon matched-pairs 
signed rank sum test. We confirm that the material submitted 
agree with the Good Publishing Practice in Physiology.49
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